Former GlaxoSmithKline CEO and R&D Boss Secure New Gigs at Biotech VC Firms

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-investor.jpg" NAME"Former GlaxoSmithKline CEO and R&D Boss Secure New Gigs at Biotech VC Firms" ALT"Former GlaxoSmithKline CEO and R&D Boss Secure New Gigs at Biotech VC Firms"September 19, 2017By…

Continue ReadingFormer GlaxoSmithKline CEO and R&D Boss Secure New Gigs at Biotech VC Firms

Biotech Startup Bonanza Continues as Emerges With $30 Million

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks4.jpg" NAME"Biotech Startup Bonanza Continues as Disarm Therapeutics Emerges With $30 Million" ALT"Biotech Startup Bonanza Continues as Disarm Therapeutics Emerges With $30 Million"September 19, 2017By Mark Terry, BioSpace... Source:…

Continue ReadingBiotech Startup Bonanza Continues as Emerges With $30 Million

Nabriva's Stock Explodes as Pneumonia Drug Wows in Two Phase III Trials

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-stock-positive.jpg" NAME"Nabriva's Stock Explodes as Pneumonia Drug Wows in Two Phase III Trials" ALT"Nabriva's Stock Explodes as Pneumonia Drug Wows in Two Phase III Trials"September 18, 2017By Alex Keown,…

Continue ReadingNabriva's Stock Explodes as Pneumonia Drug Wows in Two Phase III Trials